nib has announced an increase in its underlying operating profit for the six months to the end of December 2022 underpinned by the strong performance of its major businesses, including Australian private health insurance.
Latest Video
New Stories
-
Blood test for eight cancers arrives in Australia, but misses almost half of them
September 23, 2026 - -
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 - - Australian Biotech -
Seven Australian startups share $15.6 million to take on dementia
September 23, 2026 - - Australian Biotech -
Dimerix draws $17 million from loan facility to fund kidney drug trials to completion
September 23, 2026 - - Australian Biotech -
Actinogen's Alzheimer's pill nears its moment of truth as final trial patient is seen
September 23, 2026 - - Australian Biotech -
Patrys doses first volunteers in trial of intravenous quetiapine for delirium
September 23, 2026 - - Australian Biotech -
Lilly goes direct with a patient platform for its non-PBS medicines
September 23, 2026 - - Latest News
